Basen and blood glucose fluctuation Patient Reports February 12, 2012

Basen Side Effects Report #5061338-0
Basen side effect was reported by a Physician from JAPAN on July 03, 2006. Male patient, 65 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus, gastritis, hypertension, transient ischaemic attack and was treated with Basen. After drug was administered, patient experienced the following side effects: anti-insulin antibody positive, blood glucose fluctuation. Basen dosage: .9 MG, QD. During the same period patient was treated with NOVORAPID, NOVORAPID CHU FLEXPEN, NOVORAPID CHU FLEXPEN, NOVOLIN N, NOVOLIN N, SELBEX, AMLODIN, ASPIRIN. Patient was hospitalized. Patient recovered.